Takeda Pharmaceutical Co. Ltd. will invest €25 million and create up to 70 jobs in the construction of a new regenerative medicine facility in Dublin.
The Japanese pharmaceuticals company is set to build a new modular cell therapy facility to manufacture new stem cell therapy. The investment will also expand the company's existing facility in Grange Castle.
The new jobs will be in the quality, manufacturing and engineering sectors, Takeda Ireland Grange Castle's Plant Director Paul Keogh said.
Takeda's project is supported by the Irish government through IDA Ireland, the government agency responsible for attracting and developing foreign direct investment in the country.
